Two Phase 3 trials presented at Europe’s leading oncology conference show major survival gains: Roche’s divarasib outperforms existing targeted lung cancer drugs, while AstraZeneca’s experimental therapy doubles median survival for certain advanced stomach cancer patients; neither has yet been approved for routine use | Read More in ynet – Culture
French political turmoil may affect olim with restrictions on transferring money out of country
Trump-Netanyahu team suited to removing Iran’s regime, Netanyahu adviser tells ‘Post’
Israelis put voting first as overseas travel declines ahead of election, data shows
‘The polls never counted us’: 67,000 Israelis abroad expected to fly home to vote
Brazil election shock: anti-Israel Lula defeats Bolsonaro’s son in stunning upset
Trump goes on the attack against El-Sayed in Michigan as midterms loom
Netanyahu denies clash with IDF chief over Iran as mystery Iraq strikes raise tensions
Netanyahu rejects CNN report that Trump blocked Iran strike
South Tel Aviv activist passes away at 74
Katz: Israel never planned pre-election strike on Iran
Three terror suspects arrested in Judea and Samaria weapons raidsHow Israeli developers shaped US card game softwareBuy Twitch viewers? Real streamers tested 7 sites so you don’t have toThe Governor warns: ‘Unrestrained defense budget will lead to an increase in deficit and inflation’